Aeternum Health (AETN) Price to Sales (2021 - 2026)

Aeternum Health (AETN) has reported Price to Sales for 6 consecutive years, with 3694.88 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Price to Sales rose 61740.38% year-over-year to 3694.88 in Q1 2026; TTM through Mar 2026 was 202.4, a 4545.37% increase from a year earlier, with the FY2025 full-year figure at 7.25, down 67.55% from the prior year.
• Price to Sales was 3694.88 for Q1 2026 at Aeternum Health, up from 62.71 in the prior quarter.
• Over five years, Price to Sales peaked at 3694.88 in Q1 2026 and troughed at 5.97 in Q1 2025.
• A 5-year average of 908.12 and a median of 398.53 in 2022 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales tumbled 69.02% in 2022 and surged 61740.38% in 2026, its largest moves.
• Over 5 years, Price to Sales stood at 398.53 in 2022, then jumped by 327.57% to 1704.0 in 2023, then plunged by 93.08% to 117.84 in 2024, then slumped by 46.78% to 62.71 in 2025, then jumped by 5791.71% to 3694.88 in 2026.
• The last three Price to Sales figures came in at 3694.88 (Q1 2026), 62.71 (Q4 2025), and 176.84 (Q3 2025), per Business Quant data.